Skip to main content
SpringerLink
Log in

The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The aim of present study was to determine if factor V Leiden (FVL) mutation and angiotensin converting enzyme insertion/deletion (ACE I/D) polymorphism are associated with diabetic nephropathy (DN) among Kurdish population from Western Iran. This case–control study comprised 144 unrelated adult type 2 diabetic mellitus patients (T2DM) including 72 patients with microalbuminuria and 72 age and sex matched patients without nephropathy. The ACE I/D polymorphism and FVL mutation were detected by polymerase chain reaction (PCR) and PCR–RFLP, respectively. The frequency of FVL G1691A and ACE D allele in T2DM patients with microalbuminuria were 1.6 and 57%, respectively and in normoalbuminuric T2DM patients were 4.9 and 58.3%, respectively (P > 0.05). ACE genotypes affected on serum ACE activity and a better response to ACE inhibitor therapy (captopril) compared to angiotensin II receptor antagonist (losartan) was obtained with significant reduction of ACE activity in diabetic patients without nephropathy carrying DD genotype. However, the beneficial effect of losartan therapy was observed in microalbuminuric patients with II genotype compared to ID and DD genotypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T (2007) The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin Biochem 40:1150–1156

    Article  CAS  PubMed  Google Scholar 

  2. Kotani K, Fujiwara S, Tsuzaki K et al (2009) An association between angiotensin II type 2 receptor gene A/C3123 polymorphism and glycemic control marker in a general Japanese population. Mol Biol Rep 36:917–920

    Article  CAS  PubMed  Google Scholar 

  3. Movva S, Alluri RV, Komandur S et al (2007) Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with type 2 diabetes mellitus in Asian Indians. J Diabetes Complications 21:237–241

    Article  PubMed  Google Scholar 

  4. Arfa I, Abid A, Nouira S et al (2008) Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 9:32–36

    Article  CAS  PubMed  Google Scholar 

  5. Glenn KL, Du ZO, Eisenmann JC, Rothschild MF (2009) An alternative method for genotyping of the ACE I/D polymorphism. Mol Biol Rep 36:1305–1310

    Article  CAS  PubMed  Google Scholar 

  6. Azarpira N, Bagheri M, Raisjalali G et al (2009) Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction. Mol Biol Rep 36:909–915

    Article  CAS  PubMed  Google Scholar 

  7. Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G (2008) Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 3:1511–1525

    Article  PubMed  Google Scholar 

  8. Palomo-Pinon S, Gutierrez-Rodrigues ME, Diaz-Flores M et al (2009) DD genotype of angiotensin-converting enzyme in type 2 diabetes mellitus with renal disease in Mexican Mestizos. Nephrology 14:235–239

    Article  CAS  PubMed  Google Scholar 

  9. Akin F, Turgut S, Dursunoglu D, Turgut G, Karasu U, Gur S (2009) ACE gene polymorphism and cardiac structure in patients with insulin resistance. Mol Biol Rep 36:623–629

    Article  CAS  PubMed  Google Scholar 

  10. Mozafari H, Rahimi Z, Heidarpour A, Fallahi M, Muniz A (2009) The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase C677T among G6PD deficient individuals from Western Iran. Mol Biol Rep 36:2361–2364

    Article  CAS  PubMed  Google Scholar 

  11. Akman B, Afsar B, Ataç FB et al (2006) Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list. Transpl Proceed 38:413–415

    Article  CAS  Google Scholar 

  12. Rahimi Z, Vaisi-Raygani A, Mozafari H, Kharrazi H, Rezaei M, Nagel RL (2008) Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. J Thromb Thrombolysis 25:280–283

    Article  CAS  PubMed  Google Scholar 

  13. Rahimi Z, Mozafari H, Shariari-Ahmadi A et al (2010) Deep venous thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden. Blood Coagul Fibrinolysis 21:385–388

    Article  CAS  PubMed  Google Scholar 

  14. Rahimi Z, Mozafari H, Amiri Bigvand AH et al (2010) Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden. Clin Appl Thromb Hemost 16:430–434

    Article  CAS  PubMed  Google Scholar 

  15. Rahimi Z, Vaisi-Raygani A, Pourmotabbed T (2010) Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern Iran. Mol Biol Rep. doi:10.1007/s11033-010-0157-4

  16. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR et al (2008) Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanization, education, marital status and occupation. Singapore Med J 49:571–576

    CAS  PubMed  Google Scholar 

  17. Rahimi Z, Akramipour R, Nagel RL, Ahmadi AS, Merat A, Bahrehmand F (2006) The beta-globin gene haplotypes associated with Hb D-Los Angeles [beta121(GH4)Glu → Gln] in Western Iran. Hemoglobin 30:39–44

    Article  CAS  PubMed  Google Scholar 

  18. Nikzamir A, Nakhjavani M, Esteghamati A, Rashidi A (2008) Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition. Nephrol Dial Transplant 23:1274–1277

    Article  CAS  PubMed  Google Scholar 

  19. Nikzamir A, Esteghamati A, Feghhi M, Nakhiavani M, Rashidi A, Reza JZ (2009) The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes. J Renin Angiotensin Aldosterone Syst 10:109–114

    Article  CAS  PubMed  Google Scholar 

  20. WHO Study Group Report of a WHO consultation (1999) Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva

  21. American Diabetes Association (2004) Nephropathy in diabetes. Diabetes Care 27:S79–S83

    Article  Google Scholar 

  22. Old JM, Higgs DR (1983) Gene analysis. In: Weatherall DJ (ed) Methods in hemotology, vol. 6. The thalassemias. Livingstone, UK, pp 74–101

    Google Scholar 

  23. Nakhjavani M, Esfahnian F, Jahanshahi A et al (2007) The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes. Nephrol Dial Transplant 22:2549–2553

    Article  CAS  PubMed  Google Scholar 

  24. Maguire GA, Price CP (1985) A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum. Ann Clin Biochem 22:204–210

    CAS  PubMed  Google Scholar 

  25. Ng DPK, Tai BC, Koh D, Tan KW, Chia KS (2005) Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14727 subjects. Diabetologica 14:1008–1016

    Article  Google Scholar 

  26. Hadjadj S, Fumeron F, Roussel R et al (2008) Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects. Diabetes Care 31:1847–1852

    Article  CAS  PubMed  Google Scholar 

  27. Eroglu Z, Cetinkalp S, Erdogan M (2008) Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. J Diabetes Complications 22:186–190

    Article  PubMed  Google Scholar 

  28. Zhou JB, Yang JK, Lu JK, An YH (2010) Angiotensin-converting gene polymorphism is associated with type 2 diabetes: a meta-analysis. Mol Biol Rep 37:67–73

    Article  PubMed  Google Scholar 

  29. Kalaitzidis R, Bakris GL (2009) Effects of angiotensin II receptor blockers on diabetic nephropathy. J Hypertension 27(Suppl 5):S15–S21

    Article  CAS  Google Scholar 

  30. So WY, Ma RC, Ozaki R et al (2006) Angiotensin-converting enzyme (ACE) inhibition in type 2 diabetic patients: Interaction with ACE insertion/deletion polymorphism. Kidney Int 69:1438–1443

    CAS  PubMed  Google Scholar 

  31. Ha SK, Yong Lee S, Su Park H et al (2000) ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus. Nephrol Dial Transplant 15:1617–1623

    Article  CAS  PubMed  Google Scholar 

  32. Kfoury E, Taher A, Saghieh S, Otrock ZK, Mahfouz R (2009) The impact of inherited thrombophilia on surgery: a factor to consider before transplantation? Mol Biol Rep 36:1041–1051

    Article  CAS  PubMed  Google Scholar 

  33. Rahimi Z, Nomani H, Mozafari H et al (2009) Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T polymorphism are not associated with coronary artery disease and type 2 diabetes mellitus in Western Iran. Blood Coagul Fibrinolysis 20:252–256

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Rhazes Center for Research in Family Health and Sexual Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Zohreh Rahimi, Mansour Rezaei, Shohreh Malek-Khosravi & Habibolah Khazaie

  2. Medical Biology Research Center, Medical School, Kermanshah University of Medical Sciences, Daneshgah Avenue, P.O. Box 67148-69914, Kermanshah, Iran

    Zohreh Rahimi, Hadi Mozafari & Kheirollah Yari

  3. Department of Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Zohreh Rahimi & Asad Vaisi-Raygani

  4. Department of Pharmacology, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Vahid Felehgari

  5. Department of Endocrinology, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Mehrali Rahimi

Authors
  1. Zohreh Rahimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vahid Felehgari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehrali Rahimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hadi Mozafari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kheirollah Yari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Asad Vaisi-Raygani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mansour Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shohreh Malek-Khosravi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Habibolah Khazaie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zohreh Rahimi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahimi, Z., Felehgari, V., Rahimi, M. et al. The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol Biol Rep 38, 2117–2123 (2011). https://doi.org/10.1007/s11033-010-0338-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0338-1

Keywords

Search

Navigation